According to 2016-2017 data, over 20% of polypharmacy claims are over 10 years old, with more than 50% of them for patients aged 50 and older.

On average, construction workers are six times more likely to die from an opioid overdose death, more than any other occupation.

Healthesystems’ Chief Medical Officer spoke with WorkCompCentral regarding DEA plans to reduce opioid manufacturing.

NKTR-181 is supposed to offer a lower frequency of opioid side effects. But are more opioids really the solution we need to the opioid crisis?

Drugs to treat opioid dependence could be approved under new clinical endpoints other than reducing opioid use.

Among many findings, JAMA reports that 20% of deaths among those aged 25-34 were opioid-related.

Within the last month, laws have passed in Tennessee, Colorado, South Carolina, Oklahoma, and Hawaii.

A newly released draft guidance encourages the development of more sustained-release buprenorphine products.

Senate Bill 336 passed with a 44-6 vote and is now headed to the House.

In a special partner post with WorkCompWire, Healthesystems discusses developments in pain management, specialty drugs, and more.